Los Angeles Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$629K	Buy	179,159 +59,299	+49%	+$190K	﹤0.01%	800
2025 Q4	$234K	Buy	119,860 +94,989	+382%	+$220K	﹤0.01%	1185
2025 Q3	$54K	Sell	24,871 -12,784	-34%	-$30.2K	﹤0.01%	1338
2025 Q2	$64.8K	Buy	37,655 +21,101	+127%	+$52.5K	﹤0.01%	1285
2025 Q1	$55.1K	Sell	16,554 -45,205	-73%	-$233K	﹤0.01%	1073
2024 Q4	$457K	Hold	61,759	–	–	﹤0.01%	832
2024 Q3	$580K	Buy	61,759 +37,635	+156%	+$357K	﹤0.01%	823
2024 Q2	$193K	Buy	+24,124	New	+$259K	﹤0.01%	1132
2020 Q4	–	Sell	-7,335	Closed	-$241K	–	1528
2020 Q3	$241K	Sell	7,335 -20,766	-74%	-$637K	﹤0.01%	1338
2020 Q2	$771K	Buy	28,101 +5,855	+26%	+$192K	﹤0.01%	947
2020 Q1	$666K	Sell	22,246 -2,695	-11%	-$71.4K	﹤0.01%	817
2019 Q4	$690K	Hold	24,941	–	–	﹤0.01%	931
2019 Q3	$454K	Sell	24,941 -23,389	-48%	-$517K	﹤0.01%	1014
2019 Q2	$1.19M	Sell	48,330 -13,730	-22%	-$207K	0.01%	790
2019 Q1	$590K	Buy	+62,060	New	+$603K	﹤0.01%	1036